CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.
July 20th 2022
Adding Rivoceranib to pegylated liposomal doxorubicin — a type of chemotherapy — improved survival outcomes for patients with platinum-resistant ovarian cancer, according to recent study results.
July 5th 2022
There are many people in my life who made my cancer experience far easier. I call them my "cancer posse."
July 1st 2022
Treatment with Gen-1, a novel gene therapy, resulted in a 33% improvement in progression-free survival for patients with advanced ovarian cancer, according to recent study findings.
June 30th 2022
The study the FDA allowed to continue is investigating the safety and efficacy of the novel cancer drug ACR-368 in patients with endometrial, urothelial and ovarian cancer.
June 9th 2022
The use of Jakafi plus chemotherapy shows promise in the pre- and post-surgical treatment settings for patients with stage 3 and 4 ovarian cancer, warranting further study of the combination.
June 1st 2022
It’s good to have all the facts when you decide whether to participate in a cancer drug clinical trial—even the ones that make you swallow hard and tear up.
May 26th 2022
A clinical trial just launched to study Vaxinia — a novel cancer vaccine — in patients with previously treated advanced solid tumors.
May 25th 2022
For patients with advanced epithelial ovarian cancer, there were little — if any — differences in survival outcomes depending on when they received surgery.
May 17th 2022
Actor and cancer advocate Patrick Dempsey explains that when a loved one is diagnosed with cancer, it is important that family members make the moments they share together count.
April 26th 2022
The FDA granted a Fast Track designation to ofra-vec plus paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.
March 17th 2022
The season of spring represents new awakenings for me, and this year, I’m determined to bring an air of positivity to my life and my cancer experience.
March 8th 2022
While a recent health scare ruined a family vacation, I vowed to keep making plans and always look ahead to brighter days.
February 28th 2022
When caregivers — considered by many to be an essential part of a patient’s care team — have the tools they need to care for themselves and their loved ones, cancer outcomes can be better, too.
February 10th 2022
The MEK inhibitor trametinib should be considered a new standard of care for patients with a rare subtype of ovarian cancer, explains an expert from The University of Texas MD Anderson Cancer Center.
January 26th 2022
A patient with ovarian cancer describes how she enrolled in a clinical trial, and how it has given her a renewed sense of hope that she may find a successful treatment option.
January 21st 2022
From the death of comedian Louie Anderson after he was hospitalized for cancer treatment to former world No.1 tennis player Chris Evert’s ovarian cancer diagnosis, here’s what’s happening in the cancer landscape this week.
January 5th 2022
After a challenging year due to COVID-19 and rising blood test numbers, a woman living with ovarian cancer shares on what she’s learned and how she’s approaching 2022.
December 2nd 2021
A prostate cancer survivor explains his regret over not pushing his sister to visit the doctor as soon as she showed concerning symptoms, which were eventually revealed to be the stage 4 ovarian cancer that took her life.
November 30th 2021
Treatment programs that often use neoadjuvant chemotherapy as a strategy may help prolong survival in patients with advanced ovarian cancer compared with those that infrequently used the tactic, which may reassure patients and providers.
November 30th 2021
Mirvetuximab soravtansine had promising response rates and tolerability in patients with pretreated folate receptor alpha-high platinum-resistant ovarian cancer.
November 16th 2021
A woman with ovarian cancer explains why she was reluctant to get a port put in and why she ultimately went forward with it. “Somehow, I felt that if I got the port, I was giving in to the cancer,” she writes.
November 9th 2021
When the road ahead is unclear due to cancer, the best thing you can do is look for a new road to offer hope, a cancer survivor explains.
October 21st 2021
A woman with ovarian cancer describes how blood work numbers play a key role for patients with cancer and often dictate their thoughts and worries.
October 16th 2021
An ovarian cancer survivor explains how attending her 50th class reunion was an emotional experience as she learned of fellow classmates’ cancer experiences and struggles.
October 15th 2021
Maintenance therapy with PARP inhibitors may be a beneficial option for patients with ovarian cancer after the first line of treatment.
October 6th 2021
Health care isn’t something that is done to you. You participate in it. You’re part of the team. If your team is letting you down, say so. If they don’t do better, consider seeking health care providers who do include you in the conversation.
September 29th 2021
Maintenance therapy is meant to prevent relapse after a patient with ovarian cancer received their main treatment. Here’s an overview of what patients should know.
September 26th 2021
Learn more about the symptoms, risk factors and treatment options for ovarian cancer.
September 23rd 2021
The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.
August 31st 2021
Women with hereditary cancer syndromes must make difficult decisions about whether to keep their reproductive parts and risk dying young, or to remove them but potentially open themselves up to health issues. “Pick your hard,” writes one woman.